Section Arrow
ANIX.NASDAQ
- Anixa Biosciences
Quotes are at least 15-min delayed:2025/09/01 06:49 EDT
Regular Hours
Last
 2.99
-0.02 (-0.66%)
Day High 
3.02 
Prev. Close
3.01 
1-M High
3.3332 
Volume 
19.46K 
Bid
2.94
Ask
3.08
Day Low
2.97 
Open
3.01 
1-M Low
2.9 
Market Cap 
96.96M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.98 
20-SMA 3.02 
50-SMA 3.17 
52-W High 4.2 
52-W Low 2.07 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.38/-0.32
Enterprise Value
97.16M
Balance Sheet
Book Value Per Share
0.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
100.00K
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Quotes are at least 15-min delayed:2025/09/01 06:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.